Affinity proteomics, represented by antibody arrays, is a multiplex technology for high-throughput protein expression profiling of crude proteomes in a highly specific, sensitive, and miniaturized manner. The antibodies are individually deposited in an ordered pattern, an array, onto a solid support. Next, the sample is added, and any specifically bound proteins are detected and quantified using mainly fluorescence as the mode of detection. The binding pattern is then converted into a relative protein expression map, or protein atlas, delineating the composition of the sample at the molecular level. The technology provides unique opportunities for various applications, such as protein expression profiling, biomarker discovery, disease diagn...
Today’s proteomic analyses are generating increasing numbers of biomarkers, making it essential to p...
As many genome sequencing efforts today are completed, we are now provided with the genetic maps for...
Antibody-based microarrays is a rapidly evolving technology that has gone from the first proof-of-co...
In the quest for deciphering disease-associated biomarkers, high-performing tools for multiplexed pr...
In the quest for deciphering disease-associated biomarkers, high-performing tools for multiplexed pr...
Antibody-based microarrays are a new powerful proteomic technology that can be used to generate rapi...
Abstract The number of cancer and autoimmune disease diagnoses increases in our society, which place...
Systemic lupus erythematosus (SLE) is a severe autoimmune connective tissue disease. Our current kno...
Because of our access to human genome data and ever improving genome sequencing and proteome analysi...
In order to construct high-density, high content arrays, we have used cDNA libraries as a source of ...
Antibody-based microarrays are a rapidly emerging technology that has advanced from the first proof-...
<p>(<b>A</b>) Schematic overview of the affinity proteomics approach using antibody suspension bead ...
Antibody-based microarrays are among the novel classes of rapidly evolving proteomic technologies th...
Abstract Background Quantitative proteomics is an emerging field that encompasses multiplexed measur...
High-throughput protein arrays allow the miniaturized and parallel analysis of large numbers of diag...
Today’s proteomic analyses are generating increasing numbers of biomarkers, making it essential to p...
As many genome sequencing efforts today are completed, we are now provided with the genetic maps for...
Antibody-based microarrays is a rapidly evolving technology that has gone from the first proof-of-co...
In the quest for deciphering disease-associated biomarkers, high-performing tools for multiplexed pr...
In the quest for deciphering disease-associated biomarkers, high-performing tools for multiplexed pr...
Antibody-based microarrays are a new powerful proteomic technology that can be used to generate rapi...
Abstract The number of cancer and autoimmune disease diagnoses increases in our society, which place...
Systemic lupus erythematosus (SLE) is a severe autoimmune connective tissue disease. Our current kno...
Because of our access to human genome data and ever improving genome sequencing and proteome analysi...
In order to construct high-density, high content arrays, we have used cDNA libraries as a source of ...
Antibody-based microarrays are a rapidly emerging technology that has advanced from the first proof-...
<p>(<b>A</b>) Schematic overview of the affinity proteomics approach using antibody suspension bead ...
Antibody-based microarrays are among the novel classes of rapidly evolving proteomic technologies th...
Abstract Background Quantitative proteomics is an emerging field that encompasses multiplexed measur...
High-throughput protein arrays allow the miniaturized and parallel analysis of large numbers of diag...
Today’s proteomic analyses are generating increasing numbers of biomarkers, making it essential to p...
As many genome sequencing efforts today are completed, we are now provided with the genetic maps for...
Antibody-based microarrays is a rapidly evolving technology that has gone from the first proof-of-co...